BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11839449)

  • 1. Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion.
    Vaithiyalingam S; Khan MA
    Int J Pharm; 2002 Mar; 234(1-2):179-93. PubMed ID: 11839449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
    Nandy BC; Mazumder B
    Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and characterization of controlled release multi-particulate beads coated with starch acetate.
    Nutan MT; Soliman MS; Taha EI; Khan MA
    Int J Pharm; 2005 Apr; 294(1-2):89-101. PubMed ID: 15814233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization and evaluation of time-dependent tablets comprising an immediate and sustained release profile using artificial neural network.
    Xie H; Gan Y; Ma S; Gan L; Chen Q
    Drug Dev Ind Pharm; 2008 Apr; 34(4):363-72. PubMed ID: 18401778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of processing and curing conditions on beads coated with an aqueous dispersion of cellulose acetate phthalate.
    Williams RO; Liu J
    Eur J Pharm Biopharm; 2000 May; 49(3):243-52. PubMed ID: 10799816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of controlled release nanoparticle formulation of verapamil hydrochloride using artificial neural networks with genetic algorithm and response surface methodology.
    Li Y; Abbaspour MR; Grootendorst PV; Rauth AM; Wu XY
    Eur J Pharm Biopharm; 2015 Aug; 94():170-9. PubMed ID: 25986587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of a customized cellulose acetate butyrate dispersion for controlled drug delivery.
    Vaithiyalingam S; Nutan M; Reddy I; Khan M
    J Pharm Sci; 2002 Jun; 91(6):1512-22. PubMed ID: 12115850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
    Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
    Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough.
    Roy P; Shahiwala A
    Eur J Pharm Sci; 2009 Jun; 37(3-4):363-9. PubMed ID: 19491027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
    Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
    Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of plasticizer on heat-humidity curing of cellulose acetate phthalate coated beads.
    Williams RO; Liu J
    Pharm Dev Technol; 2001 Nov; 6(4):607-19. PubMed ID: 11775961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation, development, and performance evaluation of metoclopramide HCl oro-dispersible sustained release tablet.
    Kasliwal N; Negi JS; Jugran V; Jain R
    Arch Pharm Res; 2011 Oct; 34(10):1691-700. PubMed ID: 22076769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.
    Xu H; Zhong H; Liu M; Xu C; Gao Y
    Pharmazie; 2011 Sep; 66(9):654-61. PubMed ID: 22026119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of sustained release aceclofenac microspheres using response surface methodology.
    Deshmukh RK; Naik JB
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():197-204. PubMed ID: 25579914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and in vitro evaluation of prolonged release floating microspheres of atenolol using multicompartment dissolution apparatus.
    Bhadouriya P; Kumar M; Pathak K
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1663-71. PubMed ID: 23062186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets.
    Liu Y; Sun Y; Sun J; Zhao N; Sun M; He Z
    Int J Pharm; 2012 Apr; 426(1-2):21-28. PubMed ID: 22266529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of tamsulosin hydrochloride controlled release pellets coated with Surelease and neutralized HPMCP.
    Kim MS; Kim JS; Lee S; Jun SW; Park JS; Woo JS; Hwang SJ
    J Pharm Pharmacol; 2006 Dec; 58(12):1611-6. PubMed ID: 17331324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing.
    Passerini N; Perissutti B; Albertini B; Voinovich D; Moneghini M; Rodriguez L
    J Control Release; 2003 Mar; 88(2):263-75. PubMed ID: 12628333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and optimization of rifampicin microparticles by Box-Behnken statistical design.
    Maurya DP; Sultana Y; Aqil M; Ali A
    Pharm Dev Technol; 2012; 17(6):687-96. PubMed ID: 21486138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.